HLF · Herbalife
AI read · Good for HLF
The AI's read
Argus's view of Herbalife shares became more favorable. This remains an analyst opinion, and the report gives no new sales or profit results showing a change in Herbalife's business.
Argus Research says to keep buying Herbalife and has raised its price target from $15 to $20.
Good for HLF
Herbalife received a more favorable view from Argus, which kept its Buy rating and raised its stock target. The report gives no new sales or profit results, so this is an analyst opinion, not proof of a business change.
Get alerts for HLF
Follow Herbalife (HLF) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for HLFFree on the App Store and Google Play, or on the web.